- Home
- WEYS vs ARCT Comparison
WEYS vs ARCT Comparison
Compare WEYS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEYS
- ARCT
- Stock Information
- Founded
- WEYS 1906
- ARCT 2013
- Country
- WEYS United States
- ARCT United States
- Employees
- WEYS N/A
- ARCT N/A
- Industry
- WEYS Apparel
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- WEYS Consumer Staples
- ARCT Health Care
- Exchange
- WEYS Nasdaq
- ARCT Nasdaq
- Market Cap
- WEYS 294.5M
- ARCT 320.8M
- IPO Year
- WEYS N/A
- ARCT N/A
- Fundamental
- Price
- WEYS $28.92
- ARCT $21.20
- Analyst Decision
- WEYS
- ARCT Strong Buy
- Analyst Count
- WEYS 0
- ARCT 9
- Target Price
- WEYS N/A
- ARCT $50.88
- AVG Volume (30 Days)
- WEYS 14.3K
- ARCT 850.2K
- Earning Date
- WEYS 11-04-2025
- ARCT 11-06-2025
- Dividend Yield
- WEYS 3.73%
- ARCT N/A
- EPS Growth
- WEYS N/A
- ARCT N/A
- EPS
- WEYS 2.69
- ARCT N/A
- Revenue
- WEYS $281,051,000.00
- ARCT $122,122,000.00
- Revenue This Year
- WEYS N/A
- ARCT N/A
- Revenue Next Year
- WEYS N/A
- ARCT $28.92
- P/E Ratio
- WEYS $10.65
- ARCT N/A
- Revenue Growth
- WEYS N/A
- ARCT N/A
- 52 Week Low
- WEYS $25.51
- ARCT $8.04
- 52 Week High
- WEYS $41.05
- ARCT $23.85
- Technical
- Relative Strength Index (RSI)
- WEYS 38.70
- ARCT 54.94
- Support Level
- WEYS $29.61
- ARCT $20.21
- Resistance Level
- WEYS $30.41
- ARCT $23.60
- Average True Range (ATR)
- WEYS 0.80
- ARCT 1.64
- MACD
- WEYS -0.11
- ARCT -0.07
- Stochastic Oscillator
- WEYS 0.00
- ARCT 44.74
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.